Document is current
Any future updates will be listed below
-
Authors
Wang, Songwei
Yu, Yangyang
Li, Yinglei
Zhang, Tianzhe
Jiang, Wei https://orcid.org/0000-0002-6463-7356
Wang, Xinghuan
Liu, Ran
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32350019)
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 16 August 2024
First Online: 2 September 2024
Declarations
:
: Our work on prostatic differentiation of human ESCs and iPSCs is approved by the Medical Ethics Committee of Zhongnan Hospital of Wuhan University (2020191, titled with “the research on the evolution of prostate cancer mediated by EGFR mutation based on stem cell differentiation system”, issued on Nov 17, 2020) and the Biomedical Ethics Committee of Wuhan University (WHU-LFMD-IRB2024026, titled with “Culture and differentiation of human embryonic stem cells” and renewed on May 28, 2024). This study utilizes established human ESC lines HUES8 and H9 (obtained from Harvard Stem Cell Institute and Wicell Research Institute, respectively) [, ], not a clinical trial, so consent to participate is not applicable.
: Not applicable.
: The authors declare no competing interests.
